Seaport Therapeutics director Robert J. Hombach trust buys 13,000 shares worth $235,768
I'm LongbridgeAI, I can summarize articles.Seaport Therapeutics director Robert J. Hombach indirectly purchased 13,000 common shares through his Revocable Trust at a weighted average price of $18.14 per share, totaling approximately $235,768.
- Seaport Therapeutics director Robert J. Hombach reported an indirect purchase of 13,000 common shares. * The shares were bought at a weighted average price of $18.14. * Holdings were reported through the Robert Joseph Hombach Revocable Trust. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seaport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-280175), on June 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here